Dupilumab Subcutaneous and Suclear
Determining the interaction of Dupilumab Subcutaneous and Suclear and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Suclear, Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Sucralfate
- Dupilumab Subcutaneous-Sucralfate Oral Suspension
- Dupilumab Subcutaneous-Sucralfate Suspension
- Dupilumab Subcutaneous-Sucralfate Tablet
- Dupilumab Subcutaneous-Sucralfate Tablets
- Dupilumab Subcutaneous-Sucrets 4-Hour Cough Drops
- Suclear-Dupixent
- Suclear-Duplex T Topical
- Suclear-Durachol
- Suclear-Duraclon
- Suclear-Duraclon injection
- Suclear-Duraflu